about
Common variations in BARD1 influence susceptibility to high-risk neuroblastomaChromosome 6p22 locus associated with clinically aggressive neuroblastomaA p53 drug response signature identifies prognostic genes in high-risk neuroblastomaCommon variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastomaCombinations of genetic data in a study of neuroblastoma risk genotypes.Comparative proteomic expression profile in all-trans retinoic acid differentiated neuroblastoma cell line.Galectin-1 and its involvement in hepatocellular carcinoma aggressivenessPhenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.Integrative genomics identifies LMO1 as a neuroblastoma oncogene.Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma.The role of molecular genetics in the pathogenesis and diagnosis of neonatal sepsis.Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma.An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma.Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibilityExome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progressionRare variants in TP53 and susceptibility to neuroblastoma.Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.Total and High Molecular Weight Adiponectin Expression Is Decreased in Patients with Common Variable Immunodeficiency: Correlation with Ig Replacement Therapy.The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.Proteomic Alterations in Response to Hypoxia Inducible Factor 2α in Normoxic Neuroblastoma Cells.Common genetic variants in NEFL influence gene expression and neuroblastoma risk.Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastoma.Differences in DNA methylation profile of Th1 and Th2 cytokine genes are associated with tolerance acquisition in children with IgE-mediated cow's milk allergy.A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma.SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells.CD55 is a HIF-2α marker with anti-adhesive and pro-invading properties in neuroblastoma.A predicted functional single-nucleotide polymorphism of bone morphogenetic protein-4 gene affects mRNA expression and shows a significant association with cutaneous melanoma in Southern Italian population.Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy.Inhibition of hypoxia inducible factors combined with all-trans retinoic acid treatment enhances glial transdifferentiation of neuroblastoma cells.Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis.Mannose-binding lectin genetic analysis: possible protective role of the HYPA haplotype in the development of recurrent urinary tract infections in men.LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene.DNA methylation state of the galectin-3 gene represents a potential new marker of thyroid malignancy.Adiponectin oligomers as potential indicators of adipose tissue improvement in obese subjects.Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma.Dualistic Role of BARD1 in Cancer.
P50
Q24645352-89CEA741-B19C-4135-8211-94F4D9B322EFQ24656264-156D8D3A-5C3B-482F-9F2C-9E533E23C10EQ28537647-62B94A6C-C078-46D9-A0AC-E3BC269A9705Q28943271-9B8B7DAA-1D5E-4624-ABA8-82A9147D00C0Q30799300-1C131C98-4655-4AAD-8E5C-78131708519BQ33287185-FCF41D4E-6D39-4F0A-9396-26C4703D1CC3Q33692511-85BF0460-4D33-4C2B-A299-13B1FB3D0AD7Q33855434-DA9B35C9-C198-469D-8750-483B1A58AE77Q34152903-05B8B4CD-6C3C-44DC-B307-42EAC21DFAE5Q34501408-AA9D6E6B-5CD1-410F-8AC8-28636F38241DQ35034812-AE2B232D-B9EB-404B-83CB-FF58C5171D38Q35796345-BB96F7B0-1842-4658-9046-CB6FD5DB86B7Q36381614-BA718326-9364-4ED1-A710-EBD5692E337FQ36911240-95E682BF-644B-4441-ADA0-14E1219D57DEQ37026820-B9CFC452-7D83-4285-BC45-0285908B9C87Q37225412-ABF01288-EAAC-4A22-99B6-D9D327A4E5DEQ37696703-D4B48436-43B8-449D-BCE2-1B94BE32EC25Q37808658-685AA10C-5FD9-4CAA-AEFC-6F3398FE19B6Q38616697-F4B5D2E8-8F28-4FEF-B394-B58E6156055BQ38698465-00AC7704-BBD7-4229-BF60-0DBBFD081C6CQ38824155-FCC57693-5EB2-4989-8080-ECFA72F2A0ACQ38948164-84423F2D-A169-4828-B0FD-3BCCB7A75F2CQ39393433-BD99A7E9-27E8-4700-8391-05B5BE3050C8Q39409377-7E148CCC-FF2E-49DE-A93E-8A4936AFCE3DQ39456975-9E823E97-C238-4CDB-BA07-33C3E172A120Q39649613-4535E1C0-961C-44DC-A124-DF61BFAE674EQ39791492-1FF21B47-158C-47AC-AA50-A13E48CB8CA1Q39864749-2B2D380F-D4E7-4D0B-AAA6-649CF83DF46DQ39967845-5051CB08-FEAF-4BBF-81F4-354647350EADQ40078224-87B2881E-2A7E-4C34-ADDE-80B243893C61Q40099650-7C6F2E7D-3028-4861-9F27-CCD61EA46D8FQ40854486-F677FABA-8211-45D1-BD46-95D135FFB759Q41939991-891FB1E4-D775-4529-88EA-4FB8FA86CA3EQ42250143-DD10F696-D398-4598-8EAE-4F4260893F3FQ42315795-0050CEDE-DFFF-496C-82D5-DC2C7009DFBEQ42553510-66275D94-972F-4F4D-8BDC-A7590CD7195DQ45351237-9E47A688-3938-4997-9391-5520082EF493Q45410983-ADE5E4E8-6CF3-4F52-B205-5C1FA753F10DQ45859027-D0E99ED0-3F56-4C9F-8794-8B7444555A64Q47177315-EB3A2CC8-84C6-4ABB-A98A-95317D94E481
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mario Capasso
@ast
Mario Capasso
@en
Mario Capasso
@es
Mario Capasso
@nl
Mario Capasso
@sl
type
label
Mario Capasso
@ast
Mario Capasso
@en
Mario Capasso
@es
Mario Capasso
@nl
Mario Capasso
@sl
prefLabel
Mario Capasso
@ast
Mario Capasso
@en
Mario Capasso
@es
Mario Capasso
@nl
Mario Capasso
@sl
P108
P106
P21
P31
P496
0000-0003-3306-1259